UnitedHealth Group reports Q1 2026 earnings on April 21 amid a critical recovery phase following a difficult 2025 marked by restructuring charges and cyberattack remediation costs. The company aims to improve its medical care ratio and stabilize membership after exiting unprofitable contracts. CEO Stephen Hemsley faces his first Q1 as leader, with expectations for steady Optum Health earnings and a clearer path to profitability. Investors will watch closely for signs that the company can deliver on its recovery promises and rebuild confidence.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
